May 2019

CD34 positive stem cells recovered from cord blood remain viable after six months of cryoprotective storage process

Cord blood can be used as an alternative source for bone marrow transplantation and its use is developing into a new field of treatment for patients presenting with haematological disorders, immunological defects and specific genetic diseases; including haemoglobinopathies. The aim was to assess the viability of frozen cord blood as a source of HSC which may be suitable for transplantation. Blood specimens were obtained...

Author(s): Muhibi M. A., Mabayoje V. O. and Komolafe J. O.